Business Description
Biohaven Ltd
NAICS : 541714
SIC : 2834
ISIN : VGG1110E1079
Description
Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. Its products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 13.07 | |||||
| Equity-to-Asset | 0.62 | |||||
| Debt-to-Equity | 0.09 | |||||
| Debt-to-EBITDA | -0.03 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | 3/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | -23.6 | |||||
| 3-Year EPS without NRI Growth Rate | -20 | |||||
| 3-Year FCF Growth Rate | -28.9 | |||||
| 3-Year Book Growth Rate | 124.2 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 46.42 | |||||
| 9-Day RSI | 42.82 | |||||
| 14-Day RSI | 43.8 | |||||
| 6-1 Month Momentum % | 43.9 | |||||
| 12-1 Month Momentum % | 68.07 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.89 | |||||
| Quick Ratio | 2.89 | |||||
| Cash Ratio | 2.49 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -31.3 | |||||
| Shareholder Yield % | 0.02 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -233.93 | |||||
| ROA % | -167.04 | |||||
| ROIC % | -729.37 | |||||
| ROC (Joel Greenblatt) % | -1754.63 | |||||
| ROCE % | -223.99 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 14.2 | |||||
| Price-to-Tangible-Book | 14.87 | |||||
| EV-to-EBIT | -5.22 | |||||
| EV-to-Forward-EBIT | -7.32 | |||||
| EV-to-EBITDA | -5.27 | |||||
| EV-to-Forward-EBITDA | -7.36 | |||||
| EV-to-Forward-Revenue | 692.54 | |||||
| EV-to-FCF | -8.34 | |||||
| Price-to-Net-Current-Asset-Value | 17.91 | |||||
| Price-to-Net-Cash | 23.91 | |||||
| Earnings Yield (Greenblatt) % | -19.16 | |||||
| FCF Yield % | -11.11 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NYSE:BHVN
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Biohaven Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -9.41 | ||
| Beta | 0 | ||
| Volatility % | 57.55 | ||
| 14-Day RSI | 43.8 | ||
| 14-Day ATR ($) | 2.801891 | ||
| 20-Day SMA ($) | 48.774 | ||
| 12-1 Month Momentum % | 68.07 | ||
| 52-Week Range ($) | 26.8 - 62.21 | ||
| Shares Outstanding (Mil) | 101.12 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Biohaven Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Biohaven Ltd Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Biohaven Ltd Frequently Asked Questions
What is Biohaven Ltd(BHVN)'s stock price today?
The current price of BHVN is $46.38. The 52 week high of BHVN is $62.21 and 52 week low is $26.80.
When is next earnings date of Biohaven Ltd(BHVN)?
The next earnings date of Biohaven Ltd(BHVN) is 2025-02-28 Est..
Does Biohaven Ltd(BHVN) pay dividends? If so, how much?
Biohaven Ltd(BHVN) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers